Overview
Status
Active
Registry date
2021-10-22
Share capital
5,000.00 PLN
Registered address
ul. Zawiszy Czarnego 10, 91-829 Łódź, Poland
Financials
Revenue history
Filing timeliness
4 of 5 financial statements were filed late (the longest delay 630 days for 2021).
- 2025filed
- 202415/06/2026
- 202312/10/2024
- 202206/04/2024
- 202105/04/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Marcin Marcjan Bryszewski – President of the Management Board
Manner of representation
Each member of the management board is authorised to make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marcin Marcjan Bryszewskiage 43 | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Hammermed Medical PolskaS.K.A. | $93,061,305.58 | hammer.pl | ||
| Novama CloudS.A. | $8,295,437.50 | novama.cloud | ||
| Euroleki Gksp. z o.o. + limited partnership | $6,866,421.91 | euroleki.eu | ||
| Ana-Medsp. z o.o. | $5,202,905.16 | ana-med.eu | ||
| Geneco Groupsp. z o.o. | $156,220.50 | genecocontact.pl | ||
| Novaova Sosnowski Wadowskisp. k. | $54,452.69 | novaova.pl | ||
| Endolink PharmaS.A. | $7,191.18 | endolink.pl | ||
| Novaovasp. z o.o. | $0.16 | novaova.pl | ||
| Mezofillsp. z o.o. | – | mezofill.pl | ||
| BEH Polsp. z o.o. | – | beh-pol.com |
FAQ
The main business activity of MB Eleven focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on October 22, 2021.
The headquarters is located at: ul. Zawiszy Czarnego 10, 91-829 Łódź.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.
Last updated: 2026-10-07